The accumulation of CEBPB is likely to modulate the NRF2 cistrome, which confers increased tumor-initiating activity on NRF2-activated NSCLCs by establishing the NRF2-NOTCH3 axis (Fig. 10). The gene discussed is NFE2L2; the disease is neoplasm.